Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion type Assertion NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_head.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion evidence source_evidence_literature NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion SIO_000772 21931114 NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion wasDerivedFrom befree-20150227 NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion wasGeneratedBy ECO_0000203 NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.